Used in research and development for neurological disorders, particularly targeting myelin-associated glycoprotein (MAG) involved in nerve regeneration inhibition. This reference antibody serves as a critical tool for validating assays and developing therapeutic antibodies aimed at promoting neural repair in conditions like multiple sclerosis and peripheral neuropathies. It enables precise detection and quantification of Siglec-4a (MAG) in biological samples, supporting studies on myelin stability and axon guidance. Its high specificity makes it valuable in immunoassays, immunohistochemistry, and flow cytometry applications within neuroscience research.